Burong, Ramser O.
HRN: 17-96-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/20/2023
01/27/2023
PO
5ml
TID
Amoeba
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes